Anti-Jo-1 autoantibodies: biomarkers of severity and evolution of the disease in antisynthetase syndrome

[1] Mariampillai K(2018)Development of a new classification system for idiopathic inflammatory myopathies based on clinical manifestations and myositis-specific autoantibodies JAMA Neurol 75 1528-1537

[2] Granger B(2019)Influence of antisynthetase antibodies specificities on antisynthetase syndrome clinical spectrum time course J Clin Med 8 2013-3599

[3] Amelin D(2008)Reliability and validity of the myositis disease activity assessment tool Arthritis Rheum 58 3593-54

[4] Guiguet M(2004)International consensus outcome measures for patients with idiopathic inflammatory myopathies. Development and initial validation of myositis activity and damage indices in patients with adult onset disease Rheumatology (Oxford). 43 49-157

[5] Hachulla E(2011)Measures of adult and juvenile dermatomyositis, polymyositis, and inclusion body myositis: Physician and Patient/Parent Global Activity, Manual Muscle Testing (MMT), Health Assessment Questionnaire (HAQ)/Childhood Health Assessment Questionnaire (C-HAQ), Childhood Myositis Assessment Scale (CMAS), Myositis Disease Activity Assessment Tool (MDAAT), Disease Activity Score (DAS), Short Form 36 (SF-36), Child Health Questionnaire (CHQ), physician global damage, Myositis Damage Index

[6] Maurier F(2011)Correlation of anti-signal recognition particle autoantibody levels with creatine kinase activity in patients with necrotizing myopathy Arthritis Rheum 63 1961-4093

[7] Cavagna L(2012)Antibody levels correlate with creatine kinase levels and strength in anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase-associated autoimmune myopathy Arthritis Rheum 64 4087-11

[8] Trallero-Araguás E(1983)The precipitating antibody to an acidic nuclear protein antigen, the Jo-1, in connective tissue diseases. A marker for a subset of polymyositis with interstitial pulmonary fibrosis Arthritis Rheum. 26 604-347

[9] Meloni F(1975)Polymyositis and dermatomyositis (first of two parts) N Engl J Med 292 344-1964

[10] Cavazzana I(2017)2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups Ann Rheum Dis 76 1955-337

[1] Mariampillai K(2018)Development of a new classification system for idiopathic inflammatory myopathies based on clinical manifestations and myositis-specific autoantibodies JAMA Neurol 75 1528-1537

[2] Granger B(2019)Influence of antisynthetase antibodies specificities on antisynthetase syndrome clinical spectrum time course J Clin Med 8 2013-3599

[3] Amelin D(2008)Reliability and validity of the myositis disease activity assessment tool Arthritis Rheum 58 3593-54

[4] Guiguet M(2004)International consensus outcome measures for patients with idiopathic inflammatory myopathies. Development and initial validation of myositis activity and damage indices in patients with adult onset disease Rheumatology (Oxford). 43 49-157

[5] Hachulla E(2011)Measures of adult and juvenile dermatomyositis, polymyositis, and inclusion body myositis: Physician and Patient/Parent Global Activity, Manual Muscle Testing (MMT), Health Assessment Questionnaire (HAQ)/Childhood Health Assessment Questionnaire (C-HAQ), Childhood Myositis Assessment Scale (CMAS), Myositis Disease Activity Assessment Tool (MDAAT), Disease Activity Score (DAS), Short Form 36 (SF-36), Child Health Questionnaire (CHQ), physician global damage, Myositis Damage Index

[6] Maurier F(2011)Correlation of anti-signal recognition particle autoantibody levels with creatine kinase activity in patients with necrotizing myopathy Arthritis Rheum 63 1961-4093

[7] Cavagna L(2012)Antibody levels correlate with creatine kinase levels and strength in anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase-associated autoimmune myopathy Arthritis Rheum 64 4087-11

[8] Trallero-Araguás E(1983)The precipitating antibody to an acidic nuclear protein antigen, the Jo-1, in connective tissue diseases. A marker for a subset of polymyositis with interstitial pulmonary fibrosis Arthritis Rheum. 26 604-347

[9] Meloni F(1975)Polymyositis and dermatomyositis (first of two parts) N Engl J Med 292 344-1964

[10] Cavazzana I(2017)2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups Ann Rheum Dis 76 1955-337